698. Nacubactam Inhibits Class A β-lactamases

BACKGROUND: Nacubactam, formerly RG6080 and OP0595 (Figure 1A), is a bridged diazabicyclooctane (DBO) that inactivates class A and class C β-lactamases. Unlike avibactam, the DBO that is approved for use in combination with ceftazidime, nacubactam also inhibits penicillin binding proteins (i.e., PBP...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Barnes, Melissa D, Good, Caryn E, Bajaksouzian, Saralee, Taracila, Magdalena A, Duin, David Van, Kreiswirth, Barry N, Jacobs, Michael R, Papp-Wallace, Krisztina M, Bonomo, Robert A
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254451/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.705
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars